ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.78
1.25%
US Tech 100
19,834.00
-1.23%
S&P 500
5,842.63
1.12%
US Dollar vs CAD
1.43485
0.06%
Bitcoin
91,154.58
0.58%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nuvectis Pharma Inc (NVCT)

  7. Nuvectis Pharma Inc (NVCT) News

NVCT

Nuvectis Pharma (NVCT)

Nuvectis Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVCT
DateTimeSourceHeadlineSymbolCompany
02/27/20259:43AMBusiness WireMarket News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital MarketsNASDAQ:NVCTNuvectis Pharma Inc
02/25/20253:05PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
02/25/20258:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
02/06/20255:30AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NVCTNuvectis Pharma Inc
02/05/20258:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
02/04/20253:31PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NVCTNuvectis Pharma Inc
01/03/20255:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
01/03/20255:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
01/03/20254:00PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVCTNuvectis Pharma Inc
11/20/20247:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
11/08/20242:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
11/05/20247:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
11/05/20246:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
10/28/20247:21AMBusiness WirePESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data UpdateNASDAQ:NVCTNuvectis Pharma Inc
09/16/20246:15AMBusiness WirePESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to WatchNASDAQ:NVCTNuvectis Pharma Inc
08/29/20247:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
08/06/20248:20AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
08/06/20247:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
06/13/20243:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
06/13/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
05/13/20247:49AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
05/13/20247:47AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
05/07/20243:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
05/07/20248:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
03/05/20244:20PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
03/05/20247:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
01/05/20243:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
01/05/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
11/08/20237:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
11/08/20236:45AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:NVCT

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
NASDAQ
NB
NioCorp Developments
USOTC
HIRU
Hiru (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
BIEL
Bioelectronics (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
VPLM
Voip Pal Com (QB)
NYSE
AMC
AMC Entertainment
USOTC
CNNA
Cann American (CE)
USOTC
RDAR
Raadr (PK)
USOTC
ADIA
Adia Nutrition (PK)
USOTC
XERI
Xeriant (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads